🔗 Share this article

A shadow market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Experimental Drug Gaining Traction Online

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are urged to contact these profiles directly for source information, while also obtaining discount codes.

Thriving Commerce on Social Networks

Additionally, a robust market exists on Telegram, where groups with thousands of members share “before and after” images, injection guides and claims of next-day UK delivery. Vendors promote the substance there before redirecting buyers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Professionals Voice Worries

However, physicians and pharmacists have warned that the sale of what is still an unapproved medication in the UK is worrisome and could result in users administering products of uncertain source.

Several professionals said the demand for retatrutide could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the British medical regulations.

Several content creators attempt to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate medicines, advertising, and consumer laws, risking fines, prosecution or imprisonment.

Service Reaction and Material Removal

Based on TikTok, the service has removed violative material and prohibited related keywords and query recommendations. The organization said it was dedicated to keeping the service secure and investing in enhancing enforcement strategies.

Digital Marketplace Activities

Research also found groups with up to nine thousand members selling retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up channels with thousands of users, populated with photos of weight loss, glowing testimonials and step-by-step guides for preparing or administering at home.

After moments of joining one group, a vendor posted contact information, where the majority of transactions take place. The seller provided an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None inquired about body mass, health issues or past usage.

Item Details and Pricing

Inside these groups, posts show dark colored parcels with postal service labels, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with purified liquid, or pre-filled injectors usually sold at £160 for 20 milligrams. When asked how much time a injector should last, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for the messaging service said it actively moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting substances they cannot confirm. Although the science behind this drug is sound, these online products may not contain what they advertise,” said Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.

Her staff has already encountered individuals injured by self-injection from unconfirmed sources. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your health,” stated the doctor. “These materials could be impure or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly investigational product not yet approved … may expose users to potentially significant health risks”.